Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

(124)I-cMAb U36

Known as: 124I-cMAb U36 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Immuno-PET is an appealing concept in the detection of tumors and planning of antibody-based therapy. For this purpose, the long… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2008
2008
In patients with head and neck squamous cell carcinoma (HNSCC) radioimmunodiagnosis could offer a more specific and sensitive… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 6
  • figure 5
2005
2005
PurposeThe purpose of this study was to analyse the properties of the astatinated chimeric MAb (cMAb) U36 as a conjugate to… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
2005
2005
Data from an ongoing clinical radioimmunoscintigraphy trial indicate that99mTc-labeled monoclonal antibody (mAb) E48 is highly… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Highly Cited
2004
Highly Cited
2004
PurposeMonoclonal antibodies (MAbs) labelled with 124I are an attractive option for quantitative imaging with positron emission… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
2003
2003
We have evaluated the applicability of the [(4-isothiocyanatobenzylammonio)undecahydro-closo-dodecaborate (1-)] (DABI) linker… Expand
2002
2002
PURPOSE In an earlier Phase I radioimmunotherapy (RIT) study with rhenium-186-labeled chimeric monoclonal antibody (cMAb) U36 in… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Highly Cited
2000
Highly Cited
2000
UNLABELLED A phase I therapy study was conducted to determine the safety, maximum tolerated dose (MTD), pharmacokinetics… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Highly Cited
2000
Highly Cited
2000
Coupling of photosensitizers to tumor‐selective monoclonal antibodies ( MAbs ) is an attractive option for improving the… Expand
1997
1997
Abstract At our laboratory we are currently evaluating the suitability of mouse/human chimeric monoclonal antibodies (cmAb) for… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4